Literature DB >> 28666904

Actual target coverage after setup verification using surgical clips compared with external skin markers in postoperative breast cancer radiation therapy.

Anke van der Salm1, Lars Murrer2, Inge Steenbakkers2, Ruud Houben2, Liesbeth J Boersma2.   

Abstract

PURPOSE: After changing from offline setup verification to online setup verification using external skin markers in breast cancer patients, we noticed an increase in localized acute skin toxicity beneath the markers. Also, in vivo 3-dimensional dose measurements showed deviations between the delivered and the planned dose distributions; therefore, we investigated the accuracy of setup verification using surgical clips in the tumor bed, with a focus on target coverage of whole breast and tumor bed. METHODS AND MATERIALS: Orthogonal kilovoltage images were acquired before every fraction in 35 breast cancer patients, deriving an online 3-dimensional setup error by matching on external skin markers. In retrospect, a rematch was performed using surgical clips. For 155 fractions (ie, 5-6 fractions/patient), a cone beam computed tomography (CT) scan was available. Analysis concerned: (1) visibility of the clips, (2) migration of the clips, (3) comparison of setup errors according to both match methods, and (4) comparison of target coverage by recalculating the dose on the online setup-corrected cone beam CT scan with the patient setup according to both match methods. External validation of the surgical clip-based online setup verification was performed in 23 patients by analyzing kilovoltage images of 100 fractions, obtained after treatment.
RESULTS: All types of surgical clips could be visualized. The clip to center-of-mass distance decreased on average by 2 mm (standard deviation, 1) over the course of treatment. Setup differences between match methods were on average <0.5 mm in all directions. The reconstructed dose distributions showed standard deviations of volumes receiving 95% or 107% of prescribed dose and mean dose of the breast and boost planning target volume were similar for the planning CT and the cone beam CTs, for both match procedures. An external validation in 23 patients showed reassuring setup errors <2 mm.
CONCLUSIONS: Online setup verification using surgical clips results in comparable setup corrections and target volume coverage as verification using skin markers. By omitting skin markers acute skin toxicity beneath the markers is prevented.
Copyright © 2017 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28666904     DOI: 10.1016/j.prro.2017.04.012

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  4 in total

1.  Setup Error Assessment and Correction in Planar kV Image- Versus Cone Beam CT Image-Guided Radiation Therapy: A Clinical Study of Early Breast Cancer Treated With External Beam Partial Breast Irradiation.

Authors:  Wei Wang; Ting Yu; Min Xu; Qian Shao; Yingjie Zhang; Jianbin Li
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

2.  Breast-shape changes during radiation therapy after breast-conserving surgery.

Authors:  Tanja Alderliesten; Wilma D Heemsbergen; Anja Betgen; Rajko Topolnjak; Paula H M Elkhuizen; Corine van Vliet-Vroegindeweij; Peter Remeijer
Journal:  Phys Imaging Radiat Oncol       Date:  2018-05-31

3.  A novel, adaptable, radiographically opaque, multi-plane continuous filament marker for optimizing tissue identification, radiation planning, and radiographic follow-up.

Authors:  Sunny Mitchell; Henry Lee; Beth Baughman DuPree; David C Beyer; Michael Ulissey; Stephen R Grobmyer; Jennifer Gass; Susan Boolbol; Toni Storm-Dickerson
Journal:  Gland Surg       Date:  2019-12

4.  Setup errors and effectiveness of Optical Laser 3D Surface imaging system (Sentinel) in postoperative radiotherapy of breast cancer.

Authors:  Xiaobo Wei; Mengjiao Liu; Yun Ding; Qilin Li; Changhai Cheng; Xian Zong; Wenming Yin; Jie Chen; Wendong Gu
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.